OpGen
OPGN
$0.51
Share price
-3.21%
Change (1 day)
-37.96%
Change (1 year)
Categories
P/S ratio for OpGen (OPGN)
P/S ratio as of April 2024 (TTM): 1.96
According to OpGen 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.95659. At the end of 2023 the company had a P/S ratio of 1.16.
P/S ratio history for OpGen from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.16 | -60.01% |
| 2022 | 2.90 | -73.11% |
| 2021 | 10.8 | -0.8% |
| 2020 | 10.9 | 503.74% |
| 2019 | 1.80 | -52.74% |
| 2018 | 3.81 | 16.2% |
| 2017 | 3.28 | -47.08% |
| 2016 | 6.20 | -17.83% |
| 2015 | 7.55 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | 323 | 16,401.52% | 🇺🇸 USA |
 Enzo Biochem ENZ | 4.22 | 115.69% | 🇺🇸 USA |